CLDX Analysis

Celldex Therapeutics, Inc.
Stock Exchange: NASDAQ
Sector: healthcare
31.16
Last session price
31.16
Price now
Currency: USD
Reporting currency: USD
ISIN: US15117B2025
INN:
.

CLDX financial statements

* Numbers in thousands
Capitalization * 452 038
EV * 271 132
Number of shares * 14 507
EPS -4,12
Revenue * 7 418
Net income * -59 780
Operating profit * -49 572
Total liabilities * 26 481
Net debt * -40 355
Total assets * 235 838
Equity * 209 357
Cash and investments * 194 422
.

CLDX valuation

P/E -7,56
P/B 2,16
P/S 60,94
E/P -13
P/FCF -10,77
.

CLDX profitability

ROE -29%
ROA% -29%
ROIC% -22%